Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.

Gut

Liver Group, Division of Infection, Inflammation, and Repair, University of Southampton, Mail point 811, Level D, South Academic Block, Southampton General Hospital, Southampton S016 6YD, UK.

Published: November 2006

The diagnosis of fibrosis within liver disease is important for prognosis, stratification for treatment, and monitoring of treatment efficacy. The rising incidence and prevalence of non-alcoholic fatty liver disease (NAFLD) has driven the search for accurate non-invasive tools of liver fibrosis within this condition. With the aid of a systematic review, we explore how the field has evolved from the discovery of simple blood parameters to panel markers of liver fibrosis. We will discuss the biological plausibility, limitations, potential uses, and emerging diagnostic techniques of non-invasive markers in this rapidly expanding field.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860097PMC
http://dx.doi.org/10.1136/gut.2006.091454DOI Listing

Publication Analysis

Top Keywords

liver fibrosis
12
liver disease
12
non-invasive markers
8
non-alcoholic fatty
8
fatty liver
8
liver
6
markers associated
4
associated liver
4
fibrosis
4
fibrosis non-alcoholic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!